Stay updated with breaking news from Pharmaceutical Formulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KNOXVILLE, TN, January 10, 2022 ( ) – Provectus (OTCQB: PVCT) today announced that preclinical research on a formulation of the Company’s pharmaceutical-grade rose bengal against Gram-positive (G+) bacteria was published in Molecules, an open-access journal of chemistry.
/PRNewswire/ -- The Pharmaceutical Formulation market will register an incremental spend of about USD 183 Billion, growing at a CAGR of 6.23% during the...
/PRNewswire/ -- The Pharmaceutical Formulation market will register an incremental spend of about USD 183 Billion, growing at a CAGR of 6.23% during the...
Sited in Pennsylvania, the excipients specialist’s new facility reportedly will work toward advancing drug delivery research and boosting speed to market.
/PRNewswire/ -- The Pharmaceutical Formulation market is growing at a CAGR of 6.23% during the five-year forecast period. A targeted strategic approach to...